BBIO vs. ^GSPC
Compare and contrast key facts about BridgeBio Pharma, Inc. (BBIO) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBIO or ^GSPC.
Key characteristics
| BBIO | ^GSPC | |
|---|---|---|
| YTD Return | -29.40% | 9.47% |
| 1Y Return | 110.41% | 26.61% |
| 3Y Return (Ann) | -19.08% | 7.78% |
| Sharpe Ratio | 1.06 | 2.28 |
| Daily Std Dev | 94.15% | 11.58% |
| Max Drawdown | -92.80% | -56.78% |
| Current Drawdown | -60.61% | -0.63% |
Correlation
The correlation between BBIO and ^GSPC is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BBIO vs. ^GSPC - Performance Comparison
In the year-to-date period, BBIO achieves a -29.40% return, which is significantly lower than ^GSPC's 9.47% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BBIO vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BridgeBio Pharma, Inc. (BBIO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
BBIO vs. ^GSPC - Drawdown Comparison
The maximum BBIO drawdown since its inception was -92.80%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for BBIO and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
BBIO vs. ^GSPC - Volatility Comparison
BridgeBio Pharma, Inc. (BBIO) has a higher volatility of 10.43% compared to S&P 500 (^GSPC) at 3.61%. This indicates that BBIO's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.